Andere Sprachen BRAZIL IBRX

Index

IBX

BRIBXXINDM15

IBX

Markt geschlossen - Sao Paulo 22:23:00 03.05.2024 % 5 Tage % 1. Jan.
54.366 PTS +1,04 % Intraday Chart für BRAZIL IBRX +1,51 % -3,69 %
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Friday; ImmunityBio to Advance, Boeing to Decline
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Tuesday; MicroStrategy, Tesla to Decline
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Monday; Tesla, ImmunityBio to Advance
ImmunityBio Gaining in Tuesday Pre-Market after FDA Approval for Anktiva-Bacterium Combination for Bladder Cancer
Upcoming Big Tech Earnings Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday
Top Premarket Gainers
ImmunityBio Files Mixed Shelf
North American Morning Briefing : Markets Steady -2-
North American Morning Briefing : Stock Futures -2-
ImmunityBio Says Cancer Vaccine Trial Moving to Controlled Phase
US Equity Markets Close Lower Tuesday Ahead of Fed Meeting Minutes
Sector Update: Health Care Stocks Gain Late Afternoon
Sector Update: Health Care Stocks Rise Tuesday Afternoon
ImmunityBio Secures $320 Million Investment From Oberland Capital
Sector Update: Health Care
Top Stories at Midday: US Construction Spending Up 0.4% in November; Avangrid-PNM Resources Deal Terminated; Terreno Realty Sells California Property for $15.9 Million; ImmunityBio Secures $320 Million Investment
Indexen: Brazilië en tech in de schijnwerpers in november
Indici: Brasile e tecnologia in primo piano a novembre
Indices: Focus on tech, Brazil and China
Índices: Brasil, China y las tecnológicas, protagonistas en noviembre
Indices : le Brésil et la tech à l'honneur en novembre
Sector Update: Health Care Stocks Softer Thursday Afternoon
ImmunityBio Shares Rise After FDA Accepted Resubmitted Biologics License Application for N-803 Plus BCG
ImmunityBio Says FDA Accepted Resubmitted Biologics License Application for N-803 Plus BCG
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care Stocks Mixed in Monday Afternoon Trading
ImmunityBio Resubmits Biologics License Application for Bladder Cancer Combination Therapy
ImmunityBio Secures $40 Million Equity Financing
ImmunityBio Says Study Indicates N-803 May Contribute to Tumor Regression in Head and Neck Cancers
Wall Street Set to Open Mixed; Jobless Claims Higher Than Expected, PPI Lower Than Expected
US Futures Trends Mostly Lower Ahead of Jobs Report, Producer Price Index Data
Top Premarket Decliners
ImmunityBio Submits License Application to US FDA for N-803 Bladder Cancer Treatment
Sector Update: Health Care Stocks Drop Late Wednesday
Sector Update: Health Care Stocks Lower in Midday Trading
ImmunityBio to Raise $50 Million From Shares, Warrants Offering; Stock Falls
ImmunityBio Reports Positive Data From Metastatic Pancreatic Cancer Study
ImmunityBio to Get $157 Million Financing from Nant, Institutional Investor; Shares Rise
ImmunityBio Files Biologics License Application With FDA for Bladder Cancer Combination Immunotherapy
ImmunityBio Enrolls First Subjects in Lung Cancer Master Protocol Trial of Anktiva
Immunitybio Says Stimulated Natural Killer Cells Led to Complete Response in Leukemia Trial
Sector Update: Health Care Stocks Stabilize in Afternoon Trading
Sector Update: Health Care Stocks Gaining This Afternoon
Sector Update: Health Care
Sector Update: Health Care Stocks Gain Pre-Bell Tuesday
Detaillierte Heatmap